The company has significantly advanced its development of the new therapy for ATTR-CM, utilizing Attruby. Preliminary trial results suggests potential benefits for those suffering with this serious disease. This https://attrcm821899.imblogs.net/92011951/firm-progresses-cardiac-amyloidosis-therapy-using-attruby